These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 16472703)

  • 1. Second-line treatment options in advanced non-small cell lung cancer: current status.
    Cullen M
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S3-8. PubMed ID: 16472703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of novel second-line targeted therapies in non-small cell lung cancer.
    Massarelli E; Herbst RS
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S9-16. PubMed ID: 16472704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current approaches in chemotherapy of advanced and metastatic non-small cell lung cancer (NSCLC).
    Reck M
    Anticancer Res; 2005; 25(3A):1501-6. PubMed ID: 16033051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
    Galetta D; Rossi A; Colucci G; Gebbia V
    Oncology; 2009; 77 Suppl 1():113-21. PubMed ID: 20130439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing therapy in previously treated non-small cell lung cancer.
    Miller VA
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S25-31. PubMed ID: 16472706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
    Maione P; Gridelli C; Troiani T; Ciardiello F
    Oncologist; 2006 Mar; 11(3):274-84. PubMed ID: 16549812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Conclusion.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():37-46. PubMed ID: 18263773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stage IV NSCLC. Second-line therapy for metastatic non-small cell lung cancer].
    Quoix E
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S113-8. PubMed ID: 18971835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiangiogenetic agents and non-small cell lung cancer.
    Gridelli C; Rossi A; Maione P
    Crit Rev Oncol Hematol; 2006 Oct; 60(1):76-86. PubMed ID: 16843002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second and third line treatment in non-small cell lung cancer.
    Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving patient management in metastatic non-small cell lung cancer.
    Vansteenkiste J
    Lung Cancer; 2007 Aug; 57 Suppl 2():S12-7. PubMed ID: 17686440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
    Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geographic variation in the second-line treatment of non-small cell lung cancer.
    Edelman MJ; Sekine I; Tamura T; Saijo N
    Semin Oncol; 2006 Feb; 33(1 Suppl 1):S39-44. PubMed ID: 16472708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The need for third-line treatment in non-small cell lung cancer: an overview of new options.
    Syrigos KN; Saif MW; Karapanagiotou EM; Oikonomopoulos G; De Marinis F
    Anticancer Res; 2011 Feb; 31(2):649-59. PubMed ID: 21378351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance of second-line chemotherapy in advanced non-small cell lung cancer.].
    Zhang L
    Zhongguo Fei Ai Za Zhi; 2008 Feb; 11(1):4-9. PubMed ID: 20727256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second- and third-line treatments in non-small cell lung cancer.
    Kumar A; Wakelee H
    Curr Treat Options Oncol; 2006 Jan; 7(1):37-49. PubMed ID: 16343367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
    Gebbia V
    Expert Opin Pharmacother; 2008 Jun; 9(8):1321-37. PubMed ID: 18473707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second-line Therapy for advanced non-small-cell lung cancer.
    Hann CL; Brahmer JR
    Curr Oncol Rep; 2006 Jul; 8(4):243-7. PubMed ID: 17254522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.